Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

HIV Infection

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 176 articles: HTML format Text format

Single Articles

April 2010
1. METZNER KJ , Rauch P, von Wyl V, Leemann C, et al
   Efficient Suppression of Minority Drug-Resistant HIV Type 1 (HIV-1) Variants Present at Primary HIV-1 Infection by Ritonavir-Boosted Protease Inhibitor-Containing Antiretroviral Therapy.
   J Infect Dis. 2010;201:1063-71.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. PATEL K , Shapiro DE, Brogly SB, Livingston EG, et al
   Prenatal Protease Inhibitor Use and Risk of Preterm Birth among HIV-Infected Women Initiating Antiretroviral Drugs during Pregnancy.
   J Infect Dis. 2010;201:1035-1044.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2010
3. REITZ C , Coovadia A, Ko S, Meyers T, et al
   Initial Response to Protease-Inhibitor-Based Antiretroviral Therapy among Children Less than 2 Years of Age in South Africa: Effect of Cotreatment for Tuberculosis.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. FUCHS J , Celum C, Wang J, Hughes J, et al
   Clinical and Virologic Efficacy of Herpes Simplex Virus Type 2 Suppression by Acyclovir in a Multicontinent Clinical Trial.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. PELAK K , Goldstein DB, Walley NM, Fellay J, et al
   Host Determinants of HIV-1 Control in African Americans.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. MOTSINGER-REIF AA
   Discussion of a Genome-Wide Association Approach to Determine HIV-1 Set Point in African Americans.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles   
   
   
   
7. COPELAND KF , Brooks JI
   A Novel Use for an Old Drug: The Potential for Minocycline as Anti-HIV Adjuvant Therapy.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles   
   
   
   
8. SZETO GL , Brice AK, Yang HC, Barber SA, et al
   Minocycline Attenuates HIV Infection and Reactivation by Suppressing Cellular Activation in Human CD4(+) T Cells.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. CHENINE AL , Siddappa NB, Kramer VG, Sciaranghella G, et al
   Relative Transmissibility of an R5 Clade C Simian-Human Immunodeficiency Virus Across Different Mucosae in Macaques Parallels the Relative Risks of Sexual HIV-1 Transmission in Humans via Different Routes.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. NOWROOZALIZADEH S , Mansson F, da Silva Z, Repits J, et al
    Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. REYES-CORCHO A , Bouza-Jimenez Y
    Redefinition of Tuberculosis-Associated Immune Reconstitution Syndromes in HIV-Infected Individuals: A Need for New Clinical Tools.
    J Infect Dis. 2010;201:793-4.
    PubMed     Text format     Related articles   
    
    
    
12. SPENTZOU A , Bergin P, Gill D, Cheeseman H, et al
    Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV-1 Vaccine Candidates.
    J Infect Dis. 2010;201:720-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. GRAVITT PE , Kirk GD
    Progress and pitfalls in defining the influence of highly active antiretroviral therapy on human papillomavirus-associated cervical disease.
    J Infect Dis. 2010;201:650-2.
    PubMed     Text format     Related articles   
    
    
    February 2010
14. WEINBERG A , Lazar AA, Zerbe GO, Hayward AR, et al
    Influence of Age and Nature of Primary Infection on Varicella-Zoster Virus-Specific Cell-Mediated Immune Responses.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. VON WYL V , Ehteshami M, Symons J, Burgisser P, et al
    Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV-1 Reverse Transcriptase.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. DORIA-ROSE NA
    HIV Neutralizing Antibodies: Clinical Correlates and Implications for Vaccines.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
17. EULER Z , van Gils MJ, Bunnik EM, Phung P, et al
    Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SAX PE
    Maraviroc for Treatment-Naive Patients with HIV-1 Infection: Is the Glass Half Empty or Half Full?
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
19. KOVACS A , Karim R, Mack WJ, Xu J, et al
    Activation of CD8 T Cells Predicts Progression of HIV Infection in Women Coinfected with Hepatitis C Virus.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. COOPER DA , Heera J, Goodrich J, Tawadrous M, et al
    Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-Tropic HIV-1 Infection.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. ZOLOPA AR , Berger DS, Lampiris H, Zhong L, et al
    Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. EL HED A , Khaitan A, Kozhaya L, Manel N, et al
    Susceptibility of Human Th17 Cells to Human Immunodeficiency Virus and Their Perturbation during Infection.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. CAMARA M , Dieye TN, Seydi M, Diallo AA, et al
    Low-Level CD4(+) T Cell Activation in HIV-Exposed Seronegative Subjects: Influence of Gender and Condom Use.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. GLYNN JR , Murray J, Bester A, Nelson G, et al
    High Rates of Recurrence in HIV-Infected and HIV-Uninfected Patients with Tuberculosis.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. NARAYANAN S , Swaminathan S, Supply P, Shanmugam S, et al
    Impact of HIV Infection on the Recurrence of Tuberculosis in South India.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. CHAISSON RE , Churchyard GJ
    Recurrent Tuberculosis: Relapse, Reinfection, and HIV.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
27. MOTIWALA AS , Dai Y, Jones-Lopez EC, Hwang SH, et al
    Mutations in Extensively Drug-Resistant Mycobacterium tuberculosis That Do Not Code for Known Drug-Resistance Mechanisms.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
28. SHERMAN KE , Rouster SD, Stanford S, Blackard JT, et al
    Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV-Coinfected Subjects Treated with Interferon-Based Regimens.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MINKOFF H , Zhong Y, Burk RD, Palefsky JM, et al
    Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Positive Women.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HENEINE W
    When Do Minority Drug-Resistant HIV-1 Variants Have a Major Clinical Impact?
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
31. HALVAS EK , Wiegand A, Boltz VF, Kearney M, et al
    Low Frequency Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant Variants Contribute to Failure of Efavirenz-Containing Regimens in Treatment-Experienced Patients.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. PAREDES R , Lalama CM, Ribaudo HJ, Schackman BR, et al
    Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. HUIK K , Sadam M, Karki T, Avi R, et al
    CCL3L1 Copy Number Is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. VANPOUILLE C , Lisco A, Derudas M, Saba E, et al
    A New Class of Dual-Targeted Antivirals: Monophosphorylated Acyclovir Prodrug Derivatives Suppress Both Human Immunodeficiency Virus Type 1 and Herpes Simplex Virus Type 2.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SULEIMAN J , Zingman BS, Diaz RS, Madruga JV, et al
    Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment-Experienced Subjects: 48-Week Results of the VICTOR-E1 Phase 2 Trial.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. KIBUUKA H , Kimutai R, Maboko L, Sawe F, et al
    A Phase 1/2 Study of a Multiclade HIV-1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV-Uninfected East Africans (RV 172).
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. HAGAN H , Pouget ER, Williams IT, Garfein RL, et al
    Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ANCES BM , Vaida F, Yeh MJ, Liang CL, et al
    HIV Infection and Aging Independently Affect Brain Function as Measured by Functional Magnetic Resonance Imaging.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MUMBA NGOYI D , Lejon V, Pyana P, Boelaert M, et al
    How to Shorten Patient Follow-Up after Treatment for Trypanosoma brucei gambiense Sleeping Sickness.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
40. WORM SW , Sabin C, Weber R, Reiss P, et al
    Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SPIVAK AM , Brennan TP, O'Connell KA, Sydnor E, et al
    A Case of Seronegative HIV-1 Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. HERBECK JT , Gottlieb GS, Winkler CA, Nelson GW, et al
    Multistage Genomewide Association Study Identifies a Locus at 1q41 Associated with Rate of HIV-1 Disease Progression to Clinical AIDS.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. DEL POZO-BALADO MD , Leal M, Mendez-Lagares G, Pacheco YM, et al
    CD4(+)CD25(+/hi)CD127(lo) Phenotype Does Not Accurately Identify Regulatory T Cells in All Populations of HIV-Infected Persons.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. AHUJA SK , He W
    Double-Edged Genetic Swords and Immunity: Lesson from CCR5 and Beyond.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
45. TEMPLETON DJ , Jin F, Prestage GP, Donovan B, et al
    Circumcision and Risk of Sexually Transmissible Infections in a Community-Based Cohort of HIV-Negative Homosexual Men in Sydney, Australia.
    J Infect Dis. 2009;200:1813-1819.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. GANDHI RT , Bosch RJ, Aga E, Albrecht M, et al
    No Evidence for Decay of the Latent Reservoir in HIV-1-Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. BAKER J , Ayenew W, Quick H, Hullsiek KH, et al
    High-Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MENZO S , Vincenti D, Solmone M, Prosperi M, et al
    Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    J Infect Dis. 2009;200:1798-9.
    PubMed     Text format     Related articles   
    
    
    
49. KLEIN MB , Yang H, Delbalso L, Carbonneau J, et al
    Viral Pathogens Including Human Metapneumovirus Are the Primary Cause of Febrile Respiratory Illness in HIV-Infected Adults Receiving Antiretroviral Therapy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
50. LELIGDOWICZ A , Feldmann J, Jaye A, Cotten M, et al
    Direct Relationship between Virus Load and Systemic Immune Activation in HIV-2 Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. NDEMBI N , Goodall RL, Dunn DT, McCormick A, et al
    Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. ASMUTH DM , Brown EL, Dinubile MJ, Sun X, et al
    Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. SERRA-CASAS E , Menendez C, Bardaji A, Quinto L, et al
    The Effect of Intermittent Preventive Treatment during Pregnancy on Malarial Antibodies Depends on HIV Status and Is Not Associated with Poor Delivery Outcomes.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. STEELE AD , Cunliffe N, Tumbo J, Madhi SA, et al
    A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
    J Infect Dis. 2009;200 Suppl 1:S57-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. DESMARTEAU J
    Oral sexual behaviors and the prevalence of oral human papillomavirus infection: oropharyngeal cancer, "safer sex," and human immunodeficiency virus infection.
    J Infect Dis. 2009;200:1486.
    PubMed     Text format     Related articles   
    
    
    October 2009
56. BARZON L , Squarzon L, Militello V, Trevisan M, et al
    WU and KI Polyomaviruses in the Brains of HIV-Positive Patients With and Without Progressive Multifocal Leukoencephalopathy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. OKULICZ JF , Marconi VC, Landrum ML, Wegner S, et al
    Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long-Term Nonprogressors in the US Department of Defense HIV Natural History Study.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HUNT PW
    Natural Control of HIV-1 Replication and Long-Term Nonprogression: Overlapping but Distinct Phenotypes.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
59. MAY M , Wood R, Myer L, Taffe P, et al
    CD4(+) T Cell Count Decreases by Ethnicity among Untreated Patients with HIV Infection in South Africa and Switzerland.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. VERCAUTEREN J , Wensing AM, van de Vijver DA, Albert J, et al
    Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. WALTER J , Ghosh MK, Kuhn L, Semrau K, et al
    High Concentrations of Interleukin 15 in Breast Milk Are Associated with Protection against Postnatal HIV Transmission.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. INVERNIZZI CF , Coutsinos D, Oliveira M, Moisi D, et al
    Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C.
    J Infect Dis. 2009;200:1202-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. MIDDELKOOP K , Bekker LG, Mathema B, Shashkina E, et al
    Molecular Epidemiology of Mycobacterium tuberculosis in a South African Community with High HIV Prevalence.
    J Infect Dis. 2009;200:1207-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. TAHA TE , Kumwenda J, Cole SR, Hoover DR, et al
    Postnatal HIV-1 Transmission after Cessation of Infant Extended Antiretroviral Prophylaxis and Effect of Maternal Highly Active Antiretroviral Therapy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. JOHN-STEWART GC
    Strategic Approaches to Decrease Breast Milk Transmission of HIV-1: The Importance of Small Things.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
66. PAZ-BAILEY G , Sternberg M, Puren AJ, Markowitz LE, et al
    Improvement in Healing and Reduction in HIV Shedding with Episodic Acyclovir Therapy as Part of Syndromic Management among Men: A Randomized, Controlled Trial.
    J Infect Dis. 2009;200:1039-49.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
67. MCMAHON BJ , Dentinger CM, Bruden D, Zanis C, et al
    Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. QUAN Y , Liang C, Brenner BG, Wainberg MA, et al
    Multidrug-Resistant Variants of HIV Type 1 (HIV-1) Can Exist in Cells as Defective Quasispecies and Be Rescued by Superinfection with Other Defective HIV-1 Variants.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. KUHN L , Aldrovandi GM
    Clean Water Helps but Is Not Enough: Challenges for Safe Replacement Feeding of Infants Exposed to HIV.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
70. HARRIS JR , Greene SK, Thomas TK, Ndivo R, et al
    Effect of a Point-of-Use Water Treatment and Safe Water Storage Intervention on Diarrhea in Infants of HIV-Infected Mothers.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. COQUILLARD G , Patterson BK
    Determination of Hepatitis C Virus-Infected, Monocyte Lineage Reservoirs in Individuals With or Without HIV Coinfection.
    J Infect Dis. 2009;200:947-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. RODGER AJ , Fox Z, Lundgren JD, Kuller LH, et al
    Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients with HIV Infection.
    J Infect Dis. 2009;200:973-983.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. LE CLERC S , Limou S, Coulonges C, Carpentier W, et al
    Genomewide Association Study of a Rapid Progression Cohort Identifies New Susceptibility Alleles for AIDS (ANRS Genomewide Association Study 03).
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. FRENCH MA , King MS, Tschampa JM, da Silva BA, et al
    Serum Immune Activation Markers are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy Despite Suppression of Viral Replication and Reconstitution of CD4(+) T Cells.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
75. MARKOWITZ LE , Sternberg M, Dunne EF, McQuillan G, et al
    Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. NAIR N , Moss WJ, Scott S, Mugala N, et al
    HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus-Specific Immunoglobulin G after Vaccination and Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. AN P , Johnson R, Phair J, Kirk GD, et al
    APOBEC3B Deletion and Risk of HIV-1 Acquisition.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. SANTOSUOSSO M , Righi E, Lindstrom V, Leblanc PR, et al
    HIV-1 Envelope Protein gp120 Is Present at High Concentrations in Secondary Lymphoid Organs of Individuals with Chronic HIV-1 Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. SHARP CP , Lail A, Donfield S, Simmons R, et al
    High Frequencies of Exposure to the Novel Human Parvovirus PARV4 in Hemophiliacs and Injection Drug Users, as Detected by a Serological Assay for PARV4 Antibodies.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. SINGH KK , Sharma N, Vargas D, Liu Z, et al
    Peptides of a Novel Mycobacterium tuberculosis-Specific Cell Wall Protein for Immunodiagnosis of Tuberculosis.
    J Infect Dis. 2009;200:571-581.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. ALLISON RD , Katsounas A, Koziol DE, Kleiner DE, et al
    Association of Interleukin-15-Induced Peripheral Immune Activation with Hepatic Stellate Cell Activation in Persons Coinfected with Hepatitis C Virus and HIV.
    J Infect Dis. 2009;200:619-623.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. GUPTA SK , Komarow L, Gulick RM, Pollard RB, et al
    Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects.
    J Infect Dis. 2009;200:614-618.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. HUDGENS MG , Gilbert PB, Mascola JR, Wu CD, et al
    Power to Detect the Effects of HIV Vaccination in Repeated Low-Dose Challenge Experiments.
    J Infect Dis. 2009;200:609-613.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. JAIN MK , Yuan HJ, Adams-Huet B, Reeck A, et al
    Pegylated Interferon and Ribavirin Promote Early Evolution of Nonstructural 5A Protein in Individuals with Hepatitis C Who Demonstrate a Response to Treatment.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. MEHTA S , Hunter DJ, Mugusi FM, Spiegelman D, et al
    Perinatal Outcomes, Including Mother-to-Child Transmission of HIV, and Child Mortality and Their Association with Maternal Vitamin D Status in Tanzania.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. ASIN SN , Eszterhas SK, Rollenhagen C, Heimberg AM, et al
    HIV Type 1 Infection in Women: Increased Transcription of HIV Type 1 in Ectocervical Tissue Explants.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. ABZUG MJ , Warshaw M, Rosenblatt HM, Levin MJ, et al
    Immunogenicity and Immunologic Memory after Hepatitis B Virus Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. LEGER P , Dillingham R, Beauharnais CA, Kashuba AD, et al
    CYP2B6 Variants and Plasma Efavirenz Concentrations during Antiretroviral Therapy in Port-au-Prince, Haiti.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. PEREYRA F , Palmer S, Miura T, Block BL, et al
    Persistent Low-Level Viremia in HIV-1 Elite Controllers and Relationship to Immunologic Parameters.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
90. BANSI L , Sabin C, Gilson R, Gazzard B, et al
    Virological Response to Initial Antiretroviral Regimens Containing Abacavir or Tenofovir.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. NIJHUIS M , Wensing AM, Bierman WF, de Jong D, et al
    Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. LOCKMAN S , Creek T
    Acute Maternal HIV Infection during Pregnancy and Breast-Feeding: Substantial Risk to Infants.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
93. LIANG K , Gui X, Zhang YZ, Zhuang K, et al
    A Case Series of 104 Women Infected with HIV-1 via Blood Transfusion Postnatally: High Rate of HIV-1 Transmission to Infants through Breast-Feeding.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. MAYAUD P , Legoff J, Weiss HA, Gresenguet G, et al
    Impact of Acyclovir on Genital and Plasma HIV-1 RNA, Genital Herpes Simplex Virus Type 2 DNA, and Ulcer Healing among HIV-1-Infected African Women with Herpes Ulcers: A Randomized Placebo-Controlled Trial.
    J Infect Dis. 2009;200:216-226.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SIEVERS M , Walker UA, Sevastianova K, Setzer B, et al
    Gene Expression and Immunohistochemistry in Adipose Tissue of HIV Type 1-Infected Patients with Nucleoside Analogue Reverse-Transcriptase Inhibitor-Associated Lipoatrophy.
    J Infect Dis. 2009;200:252-262.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. STEVENS WS
    Slow Accumulation of HIV Resistance Mutations: Implications for Resource-Limited Settings?
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
97. COZZI-LEPRI A , Phillips AN, Martinez-Picado J, d'Arminio Monforte A, et al
    Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource-Limited Settings.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. BARZON L , Squarzon L, Pacenti M, Scotton PG, et al
    Detection of WU polyomavirus in cerebrospinal fluid specimen from a patient with AIDS and suspected progressive multifocal leukoencephalopathy.
    J Infect Dis. 2009;200:314-5.
    PubMed     Text format     Related articles   
    
    
    
99. KURITZKES DR
    Interleukin-2: trials and tribulations.
    J Infect Dis. 2009;200:164-5.
    PubMed     Text format     Related articles   
    
    
    
100. MESQUITA PM , Cheshenko N, Wilson SS, Mhatre M, et al
     Disruption of Tight Junctions by Cellulose Sulfate Facilitates HIV Infection: Model of Microbicide Safety.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. WALLIS RS
     Significance of Early Secreted Antigenic Target 6-Specific T Cell Depletion after HIV-1 Infection.
     J Infect Dis. 2009;200:158.
     PubMed     Text format     Related articles   
     
     
     June 2009
102. RHEE SY , Fessel WJ, Liu TF, Marlowe NM, et al
     Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. MEHTA SD , Moses S, Agot K, Parker C, et al
     Adult Male Circumcision Does Not Reduce the Risk of Incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis Infection: Results from a Randomized, Controlled Trial in Kenya.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. BUTLER LM , Dorsey G, Hladik W, Rosenthal PJ, et al
     Kaposi Sarcoma-Associated Herpesvirus (KSHV) Seroprevalence in Population-Based Samples of African Children: Evidence for At Least 2 Patterns of KSHV Transmission.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. NAICKER DD , Werner L, Kormuth E, Passmore JA, et al
     Interleukin-10 Promoter Polymorphisms Influence HIV-1 Susceptibility and Primary HIV-1 Pathogenesis.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. SUBRAMANIAM K , Metzger B, Hanau LH, Guh A, et al
     IgM(+) Memory B Cell Expression Predicts HIV-Associated Cryptococcosis Status.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. BHANICH SUPAPOL W , Remis RS, Raboud J, Millson M, et al
     Mother-to-Child Transmission of GB Virus C in a Cohort of Women Coinfected with GB Virus C and HIV in Bangkok, Thailand.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. MOLINA JM , Levy Y, Fournier I, Hamonic S, et al
     Interleukin-2 before Antiretroviral Therapy in Patients with HIV Infection: A Randomized Trial (ANRS 119).
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. LAZARO E , Godfrey SB, Stamegna P, Ogbechie T, et al
     Differential HIV Epitope Processing in Monocytes and CD4 T Cells Affects Cytotoxic T Lymphocyte Recognition.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. GRAY RT , Beagley KW, Timms P, Wilson DP, et al
     Modeling the Impact of Potential Vaccines on Epidemics of Sexually Transmitted Chlamydia trachomatis Infection.
     J Infect Dis. 2009;199:1680-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. JANOWICZ DM , Ofner S, Katz BP, Spinola SM, et al
     Experimental Infection of Human Volunteers with Haemophilus ducreyi: Fifteen Years of Clinical Data and Experience.
     J Infect Dis. 2009;199:1671-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. LEE PI , Ciccone EJ, Read SW, Asher A, et al
     Evidence for Translocation of Microbial Products in Patients with Idiopathic CD4 Lymphocytopenia.
     J Infect Dis. 2009;199:1664-1670.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. NIES-KRASKE E , Schacker TW, Condoluci D, Orenstein J, et al
     Evaluation of the Pathogenesis of Decreasing CD4(+) T Cell Counts in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy.
     J Infect Dis. 2009;199:1648-1656.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. SAAG M , Goodrich J, Fatkenheuer G, Clotet B, et al
     A Double-Blind, Placebo-Controlled Trial of Maraviroc in Treatment-Experienced Patients Infected with Non-R5 HIV-1.
     J Infect Dis. 2009;199:1638-1647.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. NOGUCHI C , Imamura M, Tsuge M, Hiraga N, et al
     G-to-A Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection.
     J Infect Dis. 2009;199:1599-1607.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
116. ZOUFALY A , Stellbrink HJ, Heiden MA, Kollan C, et al
     Cumulative HIV Viremia during Highly Active Antiretroviral Therapy Is a Strong Predictorof AIDS-Related Lymphoma.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. SABIN CA
     HIV Viremia and the Development of AIDS-Related Lymphoma in Patients Treated with Highly Active Antiretroviral Therapy.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles   
     
     
     
118. MARTINEZ LR , Mihu MR, Gacser A, Santambrogio L, et al
     Methamphetamine Enhances Histoplasmosis by Immunosuppression of the Host.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. SHET A , Mathema B, Mediavilla JR, Kishii K, et al
     Colonization and Subsequent Skin and Soft Tissue Infection Due to Methicillin-Resistant Staphylococcus aureus in a Cohort of Otherwise Healthy Adults Infected with HIV Type 1.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. SORIANO V , Mocroft A, Peters L, Rockstroh J, et al
     Reply to pascual pareja et Al.
     J Infect Dis. 2009;199:1557.
     PubMed     Text format     Related articles   
     
     
     
121. PASCUAL PAREJA JF , Montes ML, Gonzalez-Garcia J, Arribas JR, et al
     Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in European HIV-Infected Patients with Anti-HCV Antibodies.
     J Infect Dis. 2009;199:1556-7.
     PubMed     Text format     Related articles   
     
     
     
122. KRIVINE A , Launay O, Firtion G, Finkielsztejn L, et al
     Does HIV-1 Subtype D Have a Higher Risk of Vertical Transmission than Other HIV Subtypes?
     J Infect Dis. 2009;199:1553-4.
     PubMed     Text format     Related articles   
     
     
     
123. MBULAWA ZZ , Coetzee D, Marais DJ, Kamupira M, et al
     Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
     J Infect Dis. 2009;199:1514-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. SINGH DK , Anastos K, Hoover DR, Burk RD, et al
     Human Papillomavirus Infection and Cervical Cytology in HIV-Infected and HIV-Uninfected Rwandan Women.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. CAMARGO JF , Kulkarni H, Agan BK, Gaitan AA, et al
     Responsiveness of T Cells to Interleukin-7 Is Associated with Higher CD4(+) T Cell Counts in HIV-1-Positive Individuals with Highly Active Antiretroviral Therapy-Induced Viral Load Suppression.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. WILSON DP , Bowlin AK, Bavoil PM, Rank RG, et al
     Ocular Pathologic Response Elicited by Chlamydia Organisms and the Predictive Value of Quantitative Modeling.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. BUISSON S , Benlahrech A, Gazzard B, Gotch F, et al
     Monocyte-Derived Dendritic Cells from HIV Type 1-Infected Individuals Show Reduced Ability to Stimulate T Cells and Have Altered Production of Interleukin (IL)-12 and IL-10.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. HARRIGAN PR , Lima VD, Montaner JS
     Reconsidering first-line antiretroviral therapy in resource-limited settings: the need for operational research.
     J Infect Dis. 2009;199:1407-8.
     PubMed     Text format     Related articles   
     
     
     
129. ADLINGTON R , Richens J, Shahmanesh M
     First-line antiretroviral therapy in resource-limited settings: time to reconsider?
     J Infect Dis. 2009;199:1407.
     PubMed     Text format     Related articles   
     
     
     
130. SMITH RA , Anderson DJ, Pyrak CL, Preston BD, et al
     Antiretroviral Drug Resistance in HIV-2: Three Amino Acid Changes Are Sufficient for Classwide Nucleoside Analogue Resistance.
     J Infect Dis. 2009;199:1323-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. FOCOSI D
     Does contrast enhancement predict survival in progressive multifocal leukoencephalopathy?
     J Infect Dis. 2009;199:1410-1.
     PubMed     Text format     Related articles   
     
     
     April 2009
132. SEWRAM S , Singh R, Kormuth E, Werner L, et al
     Human TRIM5alpha Expression Levels and Reduced Susceptibility to HIV-1 Infection.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. AJZENBERG D , Yera H, Marty P, Paris L, et al
     Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings.
     J Infect Dis. 2009;199:1155-67.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. WIND-ROTOLO M , Durand C, Cranmer L, Reid A, et al
     Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir after Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV-1.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. DAHL V , Palmer S
     Establishment of Drug-Resistant HIV-1 in Latent Reservoirs.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles   
     
     
     
136. BAILEY RC , Mehta SD
     Circumcision's place in the vicious cycle involving herpes simplex virus type 2 and HIV.
     J Infect Dis. 2009;199:923-5.
     PubMed     Text format     Related articles   
     
     
     
137. ALTMANN A , Daumer M, Beerenwinkel N, Peres Y, et al
     Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database.
     J Infect Dis. 2009;199:999-1006.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
138. VEAZEY RS , Ling B, Green LC, Ribka EP, et al
     Topically Applied Recombinant Chemokine Analogues Fully Protect Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. BROWN ER , Otieno P, Mbori-Ngacha DA, Farquhar C, et al
     Comparison of CD4 Cell Count, Viral Load, and Other Markers for the Prediction of Mortality among HIV-1-Infected Kenyan Pregnant Women.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. GLENN FOWLER M , Owor M
     Monitoring HIV Treatment in Resource-Limited Settings: Reassuring News on the Usefulness of CD4(+) Cell Counts.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles   
     
     
     
141. WALZER PD , Djawe K, Levin L, Daly KR, et al
     Long-Term Serologic Responses to the Pneumocystis jirovecii Major Surface Glycoprotein in HIV-Positive Individuals With and Without P. jirovecii Infection.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. VAN DE VIJVER DA , Derdelinckx I, Boucher CA
     Circulating HIV Type 1 Drug Resistance Will Have Limited Impact on the Effectiveness of Preexposure Prophylaxis among Young Women in Zimbabwe.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. CARD CM , McLaren PJ, Wachihi C, Kimani J, et al
     Decreased Immune Activation in Resistance to HIV-1 Infection Is Associated with an Elevated Frequency of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. OYUGI JO , Vouriot FC, Alimonti J, Wayne S, et al
     A Common CD4 Gene Variant Is Associated with an Increased Risk of HIV-1 Infection in Kenyan Female Commercial Sex Workers.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. MARGERIDON-THERMET S , Shulman NS, Ahmed A, Shahriar R, et al
     Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. HAAS DW , Gebretsadik T, Mayo G, Menon UN, et al
     Associations between CYP2B6 Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans.
     J Infect Dis. 2009;199:872-880.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. JOHN-STEWART GC , Mbori-Ngacha D, Payne BL, Farquhar C, et al
     HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission.
     J Infect Dis. 2009;199:889-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. TAN CS , Dezube BJ, Bhargava P, Autissier P, et al
     Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation.
     J Infect Dis. 2009;199:881-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. VAN VONDEREN MG , Hassink EA, van Agtmael MA, Stehouwer CD, et al
     Increase in Carotid Artery Intima-Media Thickness and Arterial Stiffness but Improvement in Several Markers of Endothelial Function after Initiation of Antiretroviral Therapy.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. O'HARA SP , Small AJ, Gajdos GB, Badley AD, et al
     HIV-1 Tat Protein Suppresses Cholangiocyte Toll-Like Receptor 4 Expression and Defense against Cryptosporidium parvum.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. MADHI SA , Klugman KP, Kuwanda L, Cutland C, et al
     Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV-Infected and HIV-Uninfected Children 5 Years after Vaccination.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. ABZUG MJ , Pelton SI
     Prevention of Invasive Pneumococcal Disease in HIV-Infected Children: Expanding the Toolbox.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles   
     
     
     
153. JIANG W , Lederman MM, Hunt P, Sieg SF, et al
     Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. REGAN DG , Hocking JS, Wilson DP
     Reply to low et Al.
     J Infect Dis. 2009;199:768-9.
     PubMed     Text format     Related articles   
     
     
     
155. SIMEN BB , Simons JF, Hullsiek KH, Novak RM, et al
     Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes.
     J Infect Dis. 2009;199:693-701.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. SHAFER RW
     Low-Abundance Drug-Resistant HIV-1 Variants: Finding Significance in an Era of Abundant Diagnostic and Therapeutic Options.
     J Infect Dis. 2009;199:610-2.
     PubMed     Text format     Related articles   
     
     
     
157. SARRAZIN H , Wilkinson KA, Andersson J, Rangaka MX, et al
     Association between Tuberculin Skin Test Reactivity, the Memory CD4 Cell Subset, and Circulating FoxP3-Expressing Cells in HIV-Infected Persons.
     J Infect Dis. 2009;199:702-710.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. SRINIVAS NR
     Unsuspected and paradoxical potential for drug interaction by rifampin: things to ponder with antiretroviral therapy.
     J Infect Dis. 2009;199:766-7.
     PubMed     Text format     Related articles   
     
     
     
159. KIM AY , Timm J, Nolan BE, Reyor LL, et al
     Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individual.
     J Infect Dis. 2009;199:737-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
160. BAZDAR DA , Kalinowska M, Sieg SF
     Interleukin-7 Receptor Signaling Is Deficient in CD4(+) T Cells from HIV-Infected Persons and Is Inversely Associated with Aging.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. DE POKOMANDY A , Rouleau D, Ghattas G, Vezina S, et al
     Prevalence, Clearance, and Incidence of Anal Human Papillomavirus Infection in HIV-Infected Men: The HIPVIRG Cohort Study.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. MANSOOR N , Scriba TJ, de Kock M, Tameris M, et al
     HIV-1 Infection in Infants Severely Impairs the Immune Response Induced by Bacille Calmette-Guerin Vaccine.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. FONTAINE J , Coutlee F, Tremblay C, Routy JP, et al
     HIV Infection Affects Blood Myeloid Dendritic Cells after Successful Therapy and despite Nonprogressing Clinical Disease.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. CRANE M , Oliver B, Matthews G, Avihingsanon A, et al
     Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals after the Initiation of HBV-Active Antiretroviral Therapy.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. SOBNGWI-TAMBEKOU J , Taljaard D, Lissouba P, Zarca K, et al
     Effect of HSV-2 Serostatus on Acquisition of HIV by Young Men: Results of a Longitudinal Study in Orange Farm, South Africa.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. BAILEY RC , Mehta SD
     Circumcision's Place in the Vicious Cycle Involving Herpes Simplex Virus Type 2 and HIV.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles   
     
     
     
167. LEMLY DC , Shepherd BE, Hulgan T, Rebeiro P, et al
     Race and Sex Differences in Antiretroviral Therapy Use and Mortality among HIV-Infected Persons in Care.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. TOBIAN AA , Charvat B, Ssempijja V, Kigozi G, et al
     Factors Associated with the Prevalence and Incidence of Herpes Simplex Virus Type 2 Infection among Men in Rakai, Uganda.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. CONESA-BOTELLA A , Colebunders R
     Response to "Case of Yellow Fever Vaccine-Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes".
     J Infect Dis. 2009;199:601.
     PubMed     Text format     Related articles   
     
     
     
170. JOHN-STEWART GC , Mbori-Ngacha D, Payne BL, Farquhar C, et al
     HIV-1-Specific Cytotoxic T Lymphocytes and Breast Milk HIV-1 Transmission.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. BROWN AE , Gifford RJ, Clewley JP, Kucherer C, et al
     Phylogenetic Reconstruction of Transmission Events from Individuals with Acute HIV Infection: Toward More-Rigorous Epidemiological Definitions.
     J Infect Dis. 2009;199:427-431.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. TAN CS , Dezube BJ, Bhargava P, Autissier P, et al
     Detection of JC Virus DNA and Proteins in the Bone Marrow of HIV-Positive and HIV-Negative Patients: Implications for Viral Latency and Neurotropic Transformation.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. WILKIN TJ , McKinnon JE, Dirienzo AG, Mollan K, et al
     Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
174. SAGAR M , Laeyendecker O, Lee S, Gamiel J, et al
     Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission.
     J Infect Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
175. MANABE YC , Breen R, Perti T, Girardi E, et al
     Unmasked Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Disease: A Disease Spectrum after Initiation of Antiretroviral Therapy.
     J Infect Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
176. DANEL C , Moh R, Chaix ML, Gabillard D, et al
     Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults.
     J Infect Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: